We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our
Cookie Policy
.
Accept
Label
Search
SKIP TO CONTENT
SKIP NAVIGATION
Drug News
Trending
Commercial Operations
GMPs
FDA Enforcement Actions
Inspections and Audits
Postmarket Safety
Quality
Regulatory Affairs
Research and Development
Submissions and Approvals
FDAnews Drug Weekly
FDAnews
Device News
Trending
Commercial Operations
FDA Enforcement Actions
Inspections and Audits
Postmarket Safety
Quality
Regulatory Affairs
Research and Development
Submissions and Approvals
FDAnews Device Weekly
FDAnews
Books
FDAnews Books Library
Drug Books
Device Books
Training/Events
Webinar Training Pass
Events
Webinar Recordings
Resources
Form 483s Database
FDA Approved Drugs
CenterWatch
About Us
The Company
FDAnews Editorial Board
Contact Us
Advertising
Sign In
Create Account
Sign Out
My Account
Home
»
Store
» Commercial Operations
Search the Store
Shop By Category
Drug Products
Drug Books
Device Products
Device Books
Clinical Products
Shop By Media
Books
Webinar Recordings
Commercial Operations
-- Sort By --
New Arrivals
Best Sellers
Price: Low to High
Price: High to Low
A to Z
Novartis Access Program Targets 15 Essential Drugs
Price:
$40.00
Learn More
Mylan Launches Generic Invega Tablets
Price:
$40.00
Learn More
United Therapeutics Settles Sandoz Patent Dispute Over Remodulin
Price:
$40.00
Learn More
Product Hopping May Violate Antitrust Laws, FTC Says
Price:
$40.00
Learn More
PTAB Negates Novartis Patent on MS Treatment Gilenya
Price:
$40.00
Learn More
TPP Deal Calls for Five to Eight Years of Biologics Exclusivity
Price:
$40.00
Learn More
Mastering the FDA's Import Rules
Price:
$249.00
Learn More
Countries Working to Improve Access to High-Cost Drugs
Price:
$40.00
Learn More
Poor GMPs Trigger U.S. Ban of Polydrug Labs Products
Price:
$40.00
Learn More
FTC Approves Endo-Par Deal Pending Divestments
Price:
$40.00
Learn More
Impax Sues Allergan Over Parkinson’s Drug Patents
Price:
$40.00
Learn More
Amgen Sues Hospira for Biosimilar Notice, Information Sharing
Price:
$40.00
Learn More
Previous
1
2
…
12
13
14
15
16
17
18
19
20
…
27
28
Next